About Econic Biosciences
Econic Biosciences is a Healthcare company based in London (United Kingdom) founded in 2022 by Richard Koche and Shaun Foy. Developer of a platform for the discovery and development of targeted therapies for cancer. Econic Biosciences has raised $19.97 million across 3 funding rounds. Econic Biosciences offers products and services including ecDNA Targeting Therapies. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is ECONIC BIOSCIENCES LIMITED.
Company details
Econic Biosciences was founded in 2022 in London, United Kingdom, within the biotechnology sector. A platform is developed for the discovery and development of targeted cancer therapies. AI is employed to identify and characterize ecDNA, a mediator of oncogenic gene amplification and driver of tumor evolution. Development of therapies specifically targeting ecDNA is enabled to address needs of cancer patients.
- Headquarters London, United Kingdom
- Founders Richard Koche, Shaun Foy
- SectorsHealthcare
- Website econicbio.com
- Social LinkedIn
- Legal Name Econic Biosciences Limited
- Date of Incorporation 17 Dec, 2021
- Jurisdiction LONDON, ENGLAND
- Total Equity Funding$19.97M (USD)
in 3 rounds
- Latest Funding Round$4.93M (USD), Series B
May 2024
Products & Services of Econic Biosciences
Econic Biosciences offers a comprehensive portfolio of products and services, including ecDNA Targeting Therapies.
Develops drugs targeting extrachromosomal DNA for cancer therapy
Funding Insights of Econic Biosciences
Econic Biosciences has successfully raised a total of $19.97M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $4.93 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.97M
- Total Rounds 3
- Last Round Series B — $4.93M
- First Round $4.97M
(Apr 2022)
All 3 funding rounds of Econic Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $4.93M | Series B | – | – | – |
| Oct 2023 | $10.07M | Series B | – | – | – |
| Apr 2022 | $4.97M | Series A | – | – | – |
People of Econic Biosciences
8 people are tracked at Econic Biosciences (3 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Richard Koche | Co-Founder | Leadership |
Shaun Foy | Co-Founder | Leadership |
Steven Whittaker | Director, Head of Biology | Leadership |
Sunil Pancholi | Senior Manager, Scientific Operations | Team |
Fanis Michailidis, PhD | Senior Scientist | Team |
Kirsty Miller | Scientist | Team |
Beth Pennycook, PhD | Senior Scientist | Team |
Fabrizio Simeoni, PhD | Principal Scientist | Team |
Complete people profiles for Econic Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Econic Biosciences
3 dated milestones of Econic Biosciences across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Econic Biosciences is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series B, of $4.9M.
Web traffic of Econic Biosciences
The website of Econic Biosciences (econicbio.com) receives about 1.7K visits a month.
- Monthly visits1.7K
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Econic Biosciences (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Econic Biosciences
Econic Biosciences was founded in 2022.
Econic Biosciences is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Econic Biosciences is a funded company, having raised a total of $19.97M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4.97M, raised on Apr 2022.
Econic Biosciences was founded in 2022 in London, United Kingdom, within the biotechnology sector. A platform is developed for the discovery and development of targeted cancer therapies. AI is employed to identify and characterize ecDNA, a mediator of oncogenic gene amplification and driver of tumor evolution. Development of therapies specifically targeting ecDNA is enabled to address needs of cancer patients.
Econic Biosciences offers ecDNA Targeting Therapies.
Econic Biosciences operates through Econic Biosciences Limited.